These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 4068924)

  • 1. Assessment of fibrin monomer polymerisation using a microcomputer.
    Francis JL
    Med Lab Sci; 1985 Apr; 42(2):129-33. PubMed ID: 4068924
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetics of the interaction of desAABB-fibrin monomer with immobilized fibrinogen.
    Chtcheglova LA; Vogel M; Gruber HJ; Dietler G; Haeberli A
    Biopolymers; 2006 Sep; 83(1):69-82. PubMed ID: 16639743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of tryptic hydrolysates of fibrin and fibrinogen on polymerization of monomer fibrin].
    Gavrish IN
    Ukr Biokhim Zh; 1970; 42(6):736-42. PubMed ID: 5513585
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet adhesion to fibrinogen, fibrin monomer, and fibrin protofibrils in flowing blood -- the effect of fibrinogen immobilization and fibrin formation.
    Jirousková M; Dyr JE; Suttnar J; Holada K; Trnková B
    Thromb Haemost; 1997 Sep; 78(3):1125-31. PubMed ID: 9308765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Circulating levels of products of fibrinogen and fibrin monomer degradation in liver cirrhosis].
    Rocha E; López Borrasca A
    Rev Med Univ Navarra; 1974; 18(3-4):143-7. PubMed ID: 4471076
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
    Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG
    Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Functional state of the anticoagulation system during intravenous administration of fibrin monomer].
    Kudriashov BA; Molchanova LV; Kalishevskaia TM; Bazaz'ian GG; Pastorova VE; Sytina NP
    Vopr Med Khim; 1969; 15(5):483-6. PubMed ID: 5368085
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Abnormal fibrin monomer polymerization in liver disease.
    Green G; Thomson JM; Poller L; Dymock IW
    Gut; 1975 Oct; 16(10):827. PubMed ID: 1205289
    [No Abstract]   [Full Text] [Related]  

  • 9. [Soluble fibrin monomer complexes].
    Lipiński B
    Postepy Biochem; 1968; 14(3):373-81. PubMed ID: 4879748
    [No Abstract]   [Full Text] [Related]  

  • 10. Soluble crosslinked fibrin(ogen) polymers.
    Selmayr E; Müller-Berghaus G
    Thromb Haemost; 1985 Dec; 54(4):804-7. PubMed ID: 4089815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen Matsumoto I: a gamma 364 Asp-->His (GAT-->CAT) substitution associated with defective fibrin polymerization.
    Okumura N; Furihata K; Terasawa F; Nakagoshi R; Ueno I; Katsuyama T
    Thromb Haemost; 1996 Jun; 75(6):887-91. PubMed ID: 8822581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of fibrinogen/fibrin and fibronectin with collagen.
    Hörmann H; Jilek F
    Artery; 1980; 8(5):482-6. PubMed ID: 7213052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hydroxyethylpiperazine N-2 ethane sulphonic acid (HEPES) on the thrombin clotting time and fibrin polymerisation.
    Francis JL; Francis DA
    Med Lab Sci; 1984 Jul; 41(3):226-31. PubMed ID: 6482691
    [No Abstract]   [Full Text] [Related]  

  • 14. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
    Bini A; Itoh Y; Kudryk BJ; Nagase H
    Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of fragments D and double-D from fibrinogen and fibrin.
    Doolittle RF; Spraggon G; Everse SJ
    Thromb Haemost; 1999 Aug; 82(2):271-6. PubMed ID: 10605713
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrinogen, fibrin and crosslinking in aging arterial thrombi.
    McBane RD; Ford MA; Karnicki K; Stewart M; Owen WG
    Thromb Haemost; 2000 Jul; 84(1):83-7. PubMed ID: 10928475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ethanol and protamine tests in demonstration of soluble fibrin and early products of fibrin degradation.
    Konttinen YP; Kemppainen L; Turunen O
    Thromb Diath Haemorrh; 1972 Dec; 28(3):342-50. PubMed ID: 4675265
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of an inhibitor of fibrinolysis upon the intravascular clearance of fibrin monomer in dogs.
    Pratt HW; Celander DR
    J Am Osteopath Assoc; 1970 Jun; 69(10):1049-50. PubMed ID: 5201432
    [No Abstract]   [Full Text] [Related]  

  • 19. Force spectroscopy of the fibrin(ogen)-fibrinogen interaction.
    Chtcheglova LA; Haeberli A; Dietler G
    Biopolymers; 2008 Apr; 89(4):292-301. PubMed ID: 18098176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation.
    Lijnen HR; Soria J; Soria C; Collen D; Caen JP
    Thromb Haemost; 1984 Feb; 51(1):108-9. PubMed ID: 6539000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.